242 related articles for article (PubMed ID: 31356907)
21. The role of platelet and endothelial GARP in thrombosis and hemostasis.
Vermeersch E; Denorme F; Maes W; De Meyer SF; Vanhoorelbeke K; Edwards J; Shevach EM; Unutmaz D; Fujii H; Deckmyn H; Tersteeg C
PLoS One; 2017; 12(3):e0173329. PubMed ID: 28278197
[TBL] [Abstract][Full Text] [Related]
22. Theaflavin: a natural candidate to restrain thrombosis.
Zhang G; Pan Y; Cheng H; Gong S; Chu Q; Chen P
Food Funct; 2022 Jul; 13(14):7572-7581. PubMed ID: 35815842
[TBL] [Abstract][Full Text] [Related]
23. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.
Yi W; Li Q; Shen J; Ren L; Liu X; Wang Q; He S; Wu Q; Hu H; Mao X; Zhu L
PLoS One; 2014; 9(8):e102394. PubMed ID: 25115838
[TBL] [Abstract][Full Text] [Related]
24. Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase.
Huang ZS; Zeng CL; Zhu LJ; Jiang L; Li N; Hu H
J Thromb Haemost; 2010 Jun; 8(6):1383-93. PubMed ID: 20345719
[TBL] [Abstract][Full Text] [Related]
25. Humanin analogue, HNG, inhibits platelet activation and thrombus formation by stabilizing platelet microtubules.
Ren L; Li Q; You T; Zhao X; Xu X; Tang C; Zhu L
J Cell Mol Med; 2020 Apr; 24(8):4773-4783. PubMed ID: 32174022
[TBL] [Abstract][Full Text] [Related]
26. Antiplatelet aggregation and endothelial protection of I4, a new synthetic anti-diabetes sulfonylurea compound.
Ma L; Lu N; Wu G
Platelets; 2015; 26(4):342-8. PubMed ID: 24832568
[TBL] [Abstract][Full Text] [Related]
27. Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats.
Fei YX; Wang SQ; Yang LJ; Qiu YY; Li YZ; Liu WY; Xi T; Fang WR; Li YM
J Ethnopharmacol; 2017 Jul; 207():57-66. PubMed ID: 28645780
[TBL] [Abstract][Full Text] [Related]
28. Class III PI3K Positively Regulates Platelet Activation and Thrombosis via PI(3)P-Directed Function of NADPH Oxidase.
Liu Y; Hu M; Luo D; Yue M; Wang S; Chen X; Zhou Y; Wang Y; Cai Y; Hu X; Ke Y; Yang Z; Hu H
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2075-2086. PubMed ID: 28882875
[TBL] [Abstract][Full Text] [Related]
29. LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa.
Kong Y; Wang Y; Yang W; Xie Z; Li Z
J Pharmacol Sci; 2015 Apr; 127(4):462-6. PubMed ID: 25913760
[TBL] [Abstract][Full Text] [Related]
30. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
Xu HL; Feng YP
Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
[TBL] [Abstract][Full Text] [Related]
31. Reduced nicotinamide adenine dinucleotide phosphate inhibits rat platelet aggregation and p38 phosphorylation.
Gu Y; Sheng R; Wu J; Zhou Y; Qin ZH
Thromb Res; 2018 Nov; 171():121-129. PubMed ID: 30292134
[TBL] [Abstract][Full Text] [Related]
32. Effect of traditional Uyghur medicine abnormal Savda Munziq extract on rabbit platelet aggregation in vitro and rat arteriovenous shunt thrombosis in vivo.
Umar A; Yimin W; Tohti I; Upur H; Berké B; Moore N
J Ethnopharmacol; 2015 Jan; 159():184-8. PubMed ID: 25449463
[TBL] [Abstract][Full Text] [Related]
33. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
[TBL] [Abstract][Full Text] [Related]
34. The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model.
Yu KM; Inoue Y; Umeda M; Terasaki H; Chen ZY; Iwai T
Thromb Res; 2011 May; 127(5):418-25. PubMed ID: 21334044
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological actions of nobiletin in the modulation of platelet function.
Vaiyapuri S; Roweth H; Ali MS; Unsworth AJ; Stainer AR; Flora GD; Crescente M; Jones CI; Moraes LA; Gibbins JM
Br J Pharmacol; 2015 Aug; 172(16):4133-45. PubMed ID: 25988959
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp).
Liu Y; Luo W; Yang H; Fang W; Xi T; Li Y; Xiong J
Thromb Res; 2015 Aug; 136(2):319-27. PubMed ID: 26028472
[TBL] [Abstract][Full Text] [Related]
37. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
38. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.
Lien LM; Lin KH; Huang LT; Tseng MF; Chiu HC; Chen RJ; Lu WJ
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704925
[TBL] [Abstract][Full Text] [Related]
39. Short-term treatment with nitrate is not sufficient to induce in vivo antithrombotic effects in rats and mice.
Kramkowski K; Leszczynska A; Przyborowski K; Proniewski B; Marcinczyk N; Rykaczewska U; Jarmoc D; Chabielska E; Chlopicki S
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):85-94. PubMed ID: 27743016
[TBL] [Abstract][Full Text] [Related]
40. Chlorogenic acid inhibits human platelet activation and thrombus formation.
Fuentes E; Caballero J; Alarcón M; Rojas A; Palomo I
PLoS One; 2014; 9(3):e90699. PubMed ID: 24598787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
